Oroxylin A

• 产品号: O0641
• CAS号: 480-11-5
• 分子式: C16H12O5
• 分子量: 284.26348
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: Oroxylin A
• IUPAC标准名: 5,7-dihydroxy-6-methoxy-2-phenyl-4H-chromen-4-one
• IUPAC传统名: oroxylin A
• 别名: 5,7-Dihydroxy-6-methoxy-2-phenyl-4H-1-benzopyran-4-one; 6-Methoxybaicalein;; 5,7-Dihydroxy-6-methoxyflavone;

产品登记号

• CAS号: 480-11-5
• MDL号: MFCD02259441

产品性质

• Empirical Formula (Hill Notation): C16H12O5
• 纯度: ≥98% (HPLC)
• 外观: yellow powder
• 溶解度: DMSO: ≥20 mg/mL
• GHS警示词: Warning
• GHS危险声明: H302
• 欧盟危险性物质标志: 有害性(Harmful) (Xn)
• 危险公开号: 22
• 保存温度: 2-8°C
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
Oroxylin A is a flavonoid isolated from Scutellaria baicalensis, which is one of the most important medicinal herbs in traditional Korean/Chinese/Japanese medicine. The amelioration of Abeta(25-35) peptide-induced memory impairment by oroxylin A is believed to be mediated via the GABAergic neurotransmitter system after a single administration, or by reductions in Abeta(25-35) peptide-induced astrocyte and microglia activations, iNOS expression, lipid peroxidation, and increased cholinergic neurotransmission after subchronic administration.

详细说明 (简体中文)

Biochem/physiol Actions
Oroxylin A is a flavonoid isolated from Scutellaria baicalensis, which is one of the most important medicinal herbs in traditional Korean/Chinese/Japanese medicine. The amelioration of Abeta(25-35) peptide-induced memory impairment by oroxylin A is believed to be mediated via the GABAergic neurotransmitter system after a single administration, or by reductions in Abeta(25-35) peptide-induced astrocyte and microglia activations, iNOS expression, lipid peroxidation, and increased cholinergic neurotransmission after subchronic administration.